Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jeffrey Wattenberg
AddedMar 31, 2024
UpdatedMay 31, 2026
Jeffrey Wattenberg

Jeffrey Wattenberg

Board Member, Viridian Capital Advisors

CrunchbaseLinkedIn

Jeffrey Wattenberg's Career

Viridian Capital Advisors
Viridian Capital Advisors

New York City, NY, US

Board Member· Board
Z Squared
Z Squared

Wexford, PA, US

Board Member· Board
TeleCuba Holdings
TeleCuba Holdings

Florham Park, NJ, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jeffrey Wattenberg's Career

Viridian Capital Advisors
Viridian Capital Advisors
352014New York City, NY, US
Board Member· Board

Leadership at Viridian Capital Advisors

Michael SwartzMichael SwartzCo-Founder
Scott GreiperScott GreiperCo-Founder
Z Squared
Z Squared
Public$11M101996Wexford, PA, US
Board Member· Board

Leadership at Z Squared

Chris CochranChris CochranBoard Member
Dave MehalickDave MehalickFounder
Dave MehalickDave MehalickBoard Member

Similar to Z Squared

Coeptis PharmaceuticalsCoeptis PharmaceuticalsWexford, PA, USGenerics, Pharmaceuticalsest. 2018Coeptis PharmaceuticalsWexford, PA, US · est. 2018

Coeptis Pharmaceuticals: Developing and marketing high-quality branded and generic drugs globally.

Public · $1.5M30
Vinings HoldingsVinings HoldingsWexford, PA, USCell Therapy, Generic Pharmaceuticalsest. 2019Vinings HoldingsWexford, PA, US · est. 2019

Coeptis Pharmaceuticals: Developing generic drugs and cancer cell therapy platforms in the US.

Public · $171k5
ZenopharmZenopharmNew Orleans, LA, USOncology Therapeuticsest. 2014ZenopharmNew Orleans, LA, US · est. 2014

Zenopharm, a startup pharmaceutical firm, innovates oncology therapeutics for advanced breast cancer treatment.

Series B · $18.3M5
Coherus BioSciencesCoherus BioSciencesRedwood City, CA, USBiosimilar Therapeuticsest. 2010Coherus BioSciencesRedwood City, CA, US · est. 2010

Coherus BioSciences, a leading biologics firm, focuses on delivering quality biosimilar therapeutics globally.

Public · $1.3B359
TeleCuba Holdings
TeleCuba Holdings
Angel$365k52010Florham Park, NJ, US
Founder

Similar to TeleCuba Holdings

Caribbean Telecom PartnersCaribbean Telecom PartnersMarietta, GA, USTelecommunicationsest. 2010Caribbean Telecom PartnersMarietta, GA, US · est. 2010

Caribbean Telecom Partners: Your trusted telecom partner since 2010, based in Marietta, Georgia.

Series A · $6.2M6
Usconnect HoldingsUsconnect HoldingsManchester, NH, USInternet, Telecomest. 2013Usconnect HoldingsManchester, NH, US · est. 2013

USConnect: A platform for acquiring and promoting rural communication, broadband, and tech services.

Series B · $14M75
CBC Broadband HoldingsCBC Broadband HoldingsNew York City, NY, USCable, Televisionest. 2009CBC Broadband HoldingsNew York City, NY, US · est. 2009

NYC-based Cable and Pay TV service provider, established in 2009, with an annual revenue of $1.7M.

Series A · $4.9M30
DigicelDigicelKingston, Saint Andrew Parish, JMBroadband, Mobileest. 2001DigicelKingston, Saint Andrew Parish, JM · est. 2001

Digicel: Caribbean mobile network in 25 markets.

Late Stage Private · $1.3B6.5k

Jeffrey Wattenberg's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to Jeffrey Wattenberg

Boris WertzBoris WertzBoard Member · ClioZachary RubinZachary RubinCo-Founder & CEO · W8XColin WielColin WielFounder · Waypoint CapitalTroy SultanTroy SultanCo-Founder & CEO · ResourceWolfgang LudwigWolfgang LudwigCEO · WTIEric HardyEric HardyBoard Member · Henry Ford Health System